Generali Asset Management SPA SGR Sells 353 Shares of HCA Healthcare, Inc. $HCA

Generali Asset Management SPA SGR reduced its position in HCA Healthcare, Inc. (NYSE:HCA) by 2.0% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 16,912 shares of the company’s stock after selling 353 shares during the quarter. Generali Asset Management SPA SGR’s holdings in HCA Healthcare were worth $6,479,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of HCA. Cheviot Value Management LLC bought a new stake in HCA Healthcare during the first quarter valued at $26,000. Saudi Central Bank bought a new stake in shares of HCA Healthcare during the 1st quarter valued at about $26,000. WPG Advisers LLC bought a new stake in shares of HCA Healthcare during the 1st quarter valued at about $27,000. Ameriflex Group Inc. bought a new stake in HCA Healthcare during the second quarter valued at approximately $27,000. Finally, Chung Wu Investment Group LLC bought a new stake in HCA Healthcare during the second quarter valued at approximately $27,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Trading Up 0.5%

Shares of NYSE:HCA opened at $420.38 on Thursday. The company has a market cap of $98.37 billion, a price-to-earnings ratio of 17.67, a price-to-earnings-growth ratio of 1.32 and a beta of 1.40. The company has a 50-day moving average price of $408.25 and a 200-day moving average price of $377.15. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $439.01.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating analysts’ consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. During the same quarter in the prior year, the company earned $5.50 earnings per share. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were given a $0.72 dividend. The ex-dividend date of this dividend was Tuesday, September 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio is currently 12.11%.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on HCA shares. JPMorgan Chase & Co. lifted their price objective on shares of HCA Healthcare from $360.00 to $370.00 and gave the stock a “neutral” rating in a report on Monday, August 4th. Wolfe Research lowered HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research note on Monday, July 28th. Robert W. Baird boosted their target price on HCA Healthcare from $380.00 to $423.00 and gave the stock a “neutral” rating in a research report on Thursday, August 14th. UBS Group boosted their price objective on shares of HCA Healthcare from $438.00 to $495.00 and gave the stock a “buy” rating in a report on Tuesday. Finally, Wells Fargo & Company boosted their price target on shares of HCA Healthcare from $375.00 to $412.00 and gave the stock an “equal weight” rating in a research note on Tuesday, October 7th. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $431.07.

Insider Activity

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the transaction, the executive vice president owned 31,503 shares in the company, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.